Senior insider sale
CFO, Treasurer and Secretary at ORAMED PHARMACEUTICALS INC. — senior position signals high conviction
$449.1K
93.36K shares
What this filing means
GABAY AVRAHAM plans to sell 93.36K shares of ORAMED PHARMACEUTICALS INC. valued at approximately $449.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001976408-26-000608
Officer· CFO, Treasurer and Secretary
Since Jun 2019
93.36K
Shares to sell
$449.1K
Approx. market value
93.36K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
6/18/2026
93.36KTotal acquired93.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/18/2026 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 93.36K | — |
| Total | 93.36K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
93.36K
Market value
$449.1K
7/1/2026
Total
Units
93.36K
Value
$449.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/1/2026 | 93.36K | $449.1K | Nasdaq | Planned |
| Total | 93.36K | $449.1K | ||